Publicaciones en colaboración con investigadores/as de Fundación Renal Iñigo Alvarez de Toledo (12)

2016

  1. Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling

    Scientific Reports, Vol. 6

2015

  1. TNF-related weak inducer of apoptosis (TWEAK) regulates junctional proteins in tubular epithelial cells via canonical NF-κB pathway and ERK activation

    Journal of Cellular Physiology, Vol. 230, Núm. 7, pp. 1580-1593

  2. The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells

    Antioxidants and Redox Signaling, Vol. 22, Núm. 1, pp. 29-47

2014

  1. Macrophages and recently identified forms of cell death

    International Reviews of Immunology, Vol. 33, Núm. 1, pp. 9-22

  2. Osteoprotegerin and kidney disease

    Journal of Nephrology, Vol. 27, Núm. 6, pp. 607-617

  3. Unilateral ureteral obstruction: Beyond obstruction

    International Urology and Nephrology, Vol. 46, Núm. 4, pp. 765-776

2013

  1. A Polymeric Nanomedicine Diminishes Inflammatory Events in Renal Tubular Cells

    PLoS ONE, Vol. 8, Núm. 1

  2. Laser therapy in metabolic syndrome-related kidney injury

    Photochemistry and Photobiology, Vol. 89, Núm. 4, pp. 953-960

  3. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 10, pp. 1744-1755

2010

  1. Unravelling fibrosis: Two newcomers and an old foe

    Nephrology Dialysis Transplantation, Vol. 25, Núm. 11, pp. 3492-3495

2009

  1. La transcriptómica ilustra nuevas vías letales en la nefropatía diabética

    Nefrologia, Vol. 29, Núm. 1, pp. 13-19

2008

  1. TWEAK, el facilitador del daño renal agudo

    Nefrologia